Marion Lavergne - Concepedia

Author

Marion Lavergne

Also Known As

Lavergne, M., Lavergne, Marion, M. Lavergne, Marion Lavergne

Publications

307

Citations

H-Index

Concepts

All Affiliations

Marion Lavergne is an author at Université de Tours specializing in medicine, immunology, and cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	61
2	Cell Biology	2	2	43
3	Immunology	2	2	43
4	Health Sciences	1	1	18
5	Pharmacology	1	1	17

Marion Lavergne

Publications

207

Citations

H-Index

Page 1

	Year	Citations
Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells JongWook Hong, Nicholas P. Tobin, Helene Rundqvist, JNCI Journal of the National Cancer Institute	2015	72
Purification and Characterization of Avian β-Defensin 11, an Antimicrobial Peptide of the Hen Egg Virginie Hervé‐Grépinet, Sophie Réhault‐Godbert, Valérie Labas, Antimicrobial Agents and Chemotherapy	2010	61
Beneficial role of overexpression of TFPI‐2 on tumour progression in human small cell lung cancer Marion Lavergne, Marie-Lise Jourdan, Claire Bléchet, FEBS Open Bio ImmunologyBeneficial RoleCancer BiologyTumor BiologyOncology	2013	26
Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer Sophie Iochmann, Stéphanie Lerondel, Claire Bléchet, Lung Cancer Tomography ScanningOncologic ImagingCancer DetectionMedicineTumour Progression	2012	18
Pro-angiogenic effect of human kallikrein-related peptidase 12 (KLK12) in lung endothelial cells does not depend on kinin-mediated activation of B2 receptor Thomas Kryza, Gilles Lalmanach, Marion Lavergne, Biological Chemistry InflammationLung Endothelial CellsPro-angiogenic EffectCytokineSignal Transduction	2012	17
Tissue factor pathway inhibitor 2 is a potent kallikrein-related protease 12 inhibitor Marion Lavergne, Audrey Guillon‐Munos, Woodys Lenga Ma Bonda, Biological Chemistry	2021	13

Page 1